Profile data is unavailable for this security.
About the company
Henan Lingrui Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research and development, production and distribution of medicines. The Company's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The Company distributes its products throughout China, with Henan Province and Beijing as its major markets.
- Revenue in CNY (TTM)3.43bn
- Net income in CNY614.24m
- Incorporated1999
- Employees2.53k
- LocationHenan Lingrui Pharmaceutical Co LtdNo.666, Jiangjun Road, Xinxian CountyXINYANG 465550ChinaCHN
- Phone+86 3 762973569
- Fax+86 3 762987888
- Websitehttp://www.lingrui.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mabwell Shanghai Bioscience Co Ltd | 191.35m | -1.02bn | 12.76bn | 1.49k | -- | 5.30 | -- | 66.66 | -2.55 | -2.55 | 0.4789 | 6.02 | 0.0412 | 0.0472 | 16.79 | 128,337.60 | -22.02 | -37.61 | -26.37 | -45.95 | 96.84 | 81.54 | -534.78 | -2,112.26 | 1.96 | -- | 0.442 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 12.99bn | 1.24k | 23.87 | 3.18 | -- | 6.78 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.18bn | 208.25m | 13.09bn | 1.55k | 62.86 | 5.82 | -- | 11.08 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.43bn | 523.43m | 13.26bn | 8.41k | 25.54 | 1.86 | -- | 2.06 | 0.202 | 0.202 | 2.49 | 2.78 | 0.5568 | 2.39 | 4.60 | 764,058.90 | 5.02 | 6.77 | 7.25 | 10.50 | 54.36 | 63.24 | 9.02 | 11.10 | 1.53 | 40.71 | 0.1459 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
Zhejiang Jiuzhou Pharmaceutical Co Ltd | 5.25bn | 989.32m | 13.46bn | 4.88k | 13.56 | 1.54 | -- | 2.56 | 1.10 | 1.10 | 5.84 | 9.69 | 0.4523 | 1.87 | 4.36 | 1,076,055.00 | 8.52 | 10.10 | 11.07 | 13.69 | 35.80 | 34.64 | 18.83 | 16.26 | 2.07 | -- | 0.1816 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 13.47bn | 965.00 | 38.25 | 2.70 | -- | 12.55 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 14.03bn | 3.36k | 705.38 | 0.4809 | -- | 1.26 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
Anhui Huaheng Biotechnology Co Ltd | 2.04bn | 454.44m | 14.20bn | 1.69k | 31.27 | 7.42 | -- | 6.96 | 2.88 | 2.88 | 12.94 | 12.15 | 0.6196 | 5.59 | 8.04 | 1,205,674.00 | 13.71 | 16.74 | 21.59 | 22.41 | 38.49 | 39.21 | 22.13 | 22.34 | 0.4552 | 155.98 | 0.4552 | 25.20 | 36.63 | 35.72 | 40.32 | 42.84 | 82.09 | -- |
Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 14.23bn | 2.53k | 23.02 | 4.82 | -- | 4.15 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
KPC Pharmaceuticals Inc | 7.65bn | 432.35m | 14.60bn | 5.05k | 33.70 | 2.70 | -- | 1.91 | 0.5725 | 0.5725 | 10.15 | 7.15 | 0.8021 | 2.48 | 2.62 | 1,513,702.00 | 4.63 | 5.42 | 7.76 | 9.13 | 43.12 | 43.68 | 5.77 | 5.70 | 1.46 | 53.93 | 0.1688 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 14.66bn | 11.61k | 17.09 | 1.15 | -- | 1.24 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
BrightGene Bio-Medical Technology Co Ltd | 1.21bn | 195.77m | 14.75bn | 1.16k | 76.41 | 6.08 | -- | 12.14 | 0.4569 | 0.4569 | 2.87 | 5.75 | 0.2463 | 1.69 | 4.43 | 1,051,700.00 | 3.43 | 6.53 | 4.29 | 7.93 | 54.92 | 56.93 | 13.93 | 19.90 | 1.45 | 4.86 | 0.4787 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
Suzhou Zelgen Biopharmaceuticals Co Ltd | 386.57m | -260.85m | 15.06bn | 867.00 | -- | 9.45 | -- | 38.95 | -1.00 | -1.00 | 1.49 | 6.02 | 0.1621 | 0.2594 | 3.75 | 445,874.00 | -11.74 | -27.13 | -20.82 | -39.20 | 92.29 | 92.75 | -72.40 | -220.71 | 2.15 | -- | 0.3842 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
Data as of Jun 17 2024. Currency figures normalised to Henan Lingrui Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 32.80m | 5.59% |
First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 13.82m | 2.36% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 11.26m | 1.92% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 6.32m | 1.08% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 6.16m | 1.05% |
Taikang Asset Management Co. Ltd.as of 31 Dec 2023 | 4.98m | 0.85% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.91m | 0.50% |
Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 2.21m | 0.38% |
Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 2.16m | 0.37% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.95m | 0.33% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.